Post by
adamsight on May 28, 2014 8:46am
Want the stock down or?
So although its been said the Review won't end May 30th, this does not seem to be widely known.
Shat do you think the company will release some kind of update in this regard or will they let the stock tank as the deadline comes and goes?
Your thoughts?
Comment by
ShatnersRug on May 28, 2014 9:40am
I'm of the opinion that the strategic review will be extended into at least July. The new buyer might want to see how the new ICD (#5) works relative to ICDs (#1 and #2). Lots riding on ICD #5. They're obviously not content enough with how the first two have performed. If the results for #5 are poor, I suspect that the offer might be pulled or reduced.
Comment by
Junit290 on May 28, 2014 11:36am
Did they install a third ICD? I was under the impression we had stalled any further capital spending until review had reached a final decision?
Comment by
tp0052 on May 28, 2014 1:02pm
Junit290, You are correct. All capital expenditures, company wide were suspended, pending the end of the strategic review process. GLTA.
Comment by
ShatnersRug on May 28, 2014 2:11pm
Absolutely correct, tp. Capex suspended until Strat Rev is done with. However, there is nothing stopping the prospective buyer from fronting the cost of "ICD#5" in order to determine McKay's value in their eyes. They're already in the hole for the breakup fee, what's another million bucks to determine the final sale price? If and when that scenario does occur.
Comment by
Backwardblade on May 28, 2014 4:14pm
LOL! It's called STRESS dude. And I, for one don't blame him a bit.
Comment by
monzie on May 28, 2014 5:16pm
Well you've convinced me Nike. Tomorrow morning I'm gonna short the common and buy buy buy the debentures. Good lord I truly hope I'm not the only one who sees how full of it you are.
Comment by
Eyeinvestor on May 28, 2014 10:06pm
Eye own the Debs. Much as eye would like to see more people beye the Debs....it would be a really stupid and high risk strategy to short the equity and long the Deb. That would be a totally mismatched hedge. If you used $100,000 and the company was purchased for 75 cents, you would lose $90,000....quick way to turn $100 into $10. The deb is slightly less risky than the equity....that is all.